Kim A. Papp, MD, PhD

Dermatologist
Probity Medical Research and K Papp Clinical Research, Canada

Poster(s):

• (103) Efficacy and safety of roflumilast foam 0.3% in patients with psoriasis of the scalp and body in the phase 3 ARRECTOR trial
  Wednesday, October 29, 2025